viernes, 28 de julio de 2017

Ratón de biblioteca: The War Between Orthodox Medicine and Alternative Medicine






This eBook is more technical and detailed than the Introduction to Alternative Cancer Treatments. For example, it details a randomly chosen issue of the Reader's Digest and shows that a large number of pharmaceutical advertisements correlate with a large number of articles in the magazine which glorify orthodox medicine. 

But the real power of this book is in its discussions of the tactics of the pharmaceutical industry, the media, and the FDA. Great detail is shown for how these three entities manipulate and control information. 

Also, in this book is a chapter on how Linus Pauling, Ph.D. (two-time Nobel Prize winner) and Ewen Cameron, M.D. (actually M.B. in Scotland) demonstrated that Vitamin C, given in moderate doses, provided far, far better results for cancer patients than orthodox cancer treatments.

Ver:
La gran mentira sobre la vitamina C

 The two-time Nobel Prize winner and medical doctor infuriated the medical establishment because they had integrity. The tactics to discredit the Pauling/Cameron research are studied in detail. 

In short, this eBook is for those who want to dig deeper into the tactics of the medical establishment, the media, the pharmaceutical industry and the FDA. (Solicitar envio)

Ver también:
Citario/El dijo que...: Alexis Bello/"Ciencia, erudición y pragmatismo".

jueves, 27 de julio de 2017

Amazon looks set to enter healthcare market

.
Marco Ricci July 24, 2017 

All-conquering e-commerce giant Amazon could soon be entering the healthcare market.

 The exact extent of Amazon’s ambitions aren’t yet clear, but rumours that it wants to enter the pharmacy market – including selling prescription medicines direct to consumers – has sent a chill down the spines of many existing healthcare company execs. 

CNBC reported in May that Amazon was assembling a team to break into the $400 billion US pharmacy market. Its first stepping stone to that destination could be the acquisition of Whole Foods, a chain of upmarket grocery stores which has 450 locations across the country. These shops could accommodate pharmacies to provide face-to-face contact with millions of American customers. 

Now Amazon has just hired a top technology executive in Missy Krasner, a former employee of corporate cloud content management company Box.

Ver:
Amazon nabs a top Box exec in health as it goes after the medical industry






At Box, Krasner was the Vice President and managing director of the firm’s Healthcare and Life Sciences division. Prior to that, she had a five-year stint at Google where she was a founding member of the now defunct Google Health

Reports are suggesting that Krasner could find a role Amazon Web Services, the company’s cloud division, which already has links to major health names like Bristol-Myers Squibb and healthcare software company Orion Health

The appointment could be part of a larger push into the pharmaceutical space – as also reported by CNBC – which has already begun with the company selling medical supplies in the US. 

Rather than establishing a bricks-and-mortar presence, Amazon may well want to focus on developing online pharmacy services. However the sector is more heavily regulated than other sectors, whether that is the US or other countries. The company has tried to enter the market once before – in the late 1990s it formed an alliance with Drugstore.com, but the venture ultimately proved unsuccessful. 

Rumours about Amazon’s potential in healthcare began earlier this year when the company’s voice-enabled personal assistant, Alexa, was heavily showcased at the Consumer Electronics Show.

Ver:
Amazon Now Wants To Refill Prescriptions

Mas


Ver también:

Te lo digo y te lo repito. Y te lo vuelvo a repetir...Farmacia on-line NO-LINE

miércoles, 26 de julio de 2017

Te lo digo y te lo repito. Y te lo vuelvo a repetir...Farmacia on-line NO-LINE


Yo, repetidas veces, manifiesté ser esceptico ante las "farmacias on-line"

 

Farmacia "on line"


Tras dos años de su regulación en España, la venta de medicamentos sin receta a través de la web de las farmacias es anecdótica. Apenas el 1,2% de todas las boticas españolas -266 de las 21.968 del total- ha puesto en marcha desde entonces el comercio online de sus productos farmacéuticos sin prescripción, los únicos que son legales en nuestro país. 

Al fracaso de este negocio en nuestro país -que sí ha funcionado en otros países europeos como Francia, Alemania, Portugal o Suecia- se ha unido en las últimas fechas la queja de varios de estos farmacéuticos que sí han dado el paso a la venta online. Según ha hecho público la propia patronal de las farmacias, Fefe, en algunas Comunidades Autónomas, como Madrid y Galicia, se han producido en los últimos meses varias sanciones a los dueños de estas farmacias por incumplir la normativa de publididad. 

"El riesgo de incumplir algún precepto referido a la publicidad de la farmacia resulta muy alto en estas dos regiones, ya que sus Leyes de Ordenación prevén importantes sanciones, y a las inspecciones les resulta muy cómodo revisar estos aspectos en las farmacias que venden productos por Internet, sin salir de su despacho", asegura la patronal. 

 "En algunos casos se han analizado también los descuentos e incluso los gastos de envío, que si son nulos o inferiores al coste real podrían considerarse descuentos no autorizados, ya que en estos medicamentos existe el límite legal del 10% de descuento. Desde la Asociación Española de Asesores de Farmacia (Asefarma) confirman estas sanciones en 2016. 

"La puesta en marcha de dichas páginas web así como de las dedicadas a parafarmacia ha generado en el último año la imposición de sanciones a farmacéuticos por realizar publicidad a través de medios online. Prácticamente toda publicidad está prohibida, según la interpretación restrictiva que hace la Consejería de Sanidad de la ley de Ordenación y Atención Farmacéutica de la Comunidad de Madrid. 

Además, apunta Fefe, existe la obligación de separar la venta de medicamentos de otros productos lo que implica una dificultad añadida para el acceso a los clientes.(Ver)

martes, 25 de julio de 2017

Creatividad: Viagra & Cialis dejan la promocion en TV?

Ver

Is it the end of a controversial era? Erectile dysfunction ads will no longer be seen during televised NFL football games, according to a report in Advertising Age. 



Neither Pfizer’s Viagra nor Eli Lilly’s Cialis will likely air TV ads during the NFL season; neither one bought fall football time in the recent upfronts, unnamed media insiders told the publication. Viagra ads have not aired on TV since May 15, according to data from real-time TV ad tracker iSpot.tv. Cialis, however, is still running a fairly strong TV ad schedule, having spent more than $8 million on TV ads in the last 30 days, according to iSpot.tv. It ranked eighth in pharma ad spending overall for the month of June. 

A Pfizer spokesman declined to comment on the possible NFL departure, saying that the company does not disclose any marketing plans for "competitive reasons." 

The apparent reason for the football fadeaway is that both drugs will soon lose patent exclusivity, and competition is on the way. 
A Viagra generic from Teva Pharmaceuticals is expected to hit the market in December. 

Both drugmakers have publicly discussed OTC plans for their ED drugs, but even approval wouldn’t guarantee TV advertising. Drugs that move from prescription to OTC tend to drop branded TV advertising in the process, although there are some exceptions, such as in the allergy space, where new-to-OTC drugs such as GSK’s Flonase continued aggressive TV buys with sales success. Pfizer´s Nexium purple pill is another instance of continued branded TV marketing after an OTC switch. 

Pfizer is evaluating a number of prescription drugs for a potential switch to nonprescription status. We are focused on categories that will have the greatest positive impact to people and the healthcare system overall," the spokesman said. 

Lilly struck a deal with Sanofi in 2014 to begin work on an OTC Cialis to be marketed by Sanofi in the U.S., Europe, Canada and Australia.

Ver:
Sanofi & Lilly announce licensing agreement for Cialis® (tadalafil) OTC

The move away from ED ads on TV is one that possibly only the TV channels and media buyers will mourn. ED commercials have been lampooned and criticized since they began, even though the drugs have proven a solid payday for viewer-bereft TV channels.



Last year, Viagra spent around $31 million on NFL TV ads during the season, while Cialis spent about $22 million, according to iSpot.tv data. (Ver)

Most recently, Cialis has bought time in Fox's coverage of the 2017 U.S. Open golf tournament and in select MLB games and Nascar races. The brand has also snapped up inventory in general entertainment programming such as TNT's new drama series "Claws" and ABC's "Shark Tank," as well as in NBC and CBS's respective nightly newscasts. 

While Cialis remains committed to a summer TV schedule, its creative rotation has shown signs of stagnation. After pulling two of its three active commercials in early May, the brand is now down to a single 60-second spot ("A Moment Turns Romantic"), which it first introduced in September 2016, just in time for the new fall TV season. (Más)

domingo, 23 de julio de 2017

BAYER siente su orgullo LGBT



La tradicional bandera multicolor fue izada en las oficinas centrales de la farmacéutica. Bayer amaneció con la bandera multicolor que representa la diversidad sexual flameando en su sede central, en Alemania. 

La misma fue izada por los trabajadores de la empresa y en defensa de la comunidad bisexuales, gays, transexuales y lesbianas (LGTB). 

Bayer hace varios años adoptó una política de apoyo hacia el movimiento LGTB impulsada por varios de sus trabajadores, quienes se agruparon en el grupo ¨Blend¨ y tienen presencia en en Brasil, Estados Unidos, China y Alemania.

“We appreciate the wealth of ideas, 
backgrounds and perspectives 
our employees bring to the Group. 
We are convinced 
of the very positive effect 
this has on our business. 
This is why we create 
a working environment 
that allows all employees 
to freely express 
their sexual orientation 
and identity.” 

Member of the Board of 
Management Bayer AG. 

Bajo el lema “nuestro mundo es colorido, nosotros también”, el grupo Blend se sumó al desfile CSD -Christopher Street Day-, que reúne a cerca de 800.000 personas cada año. (July 9) (Ver)

sábado, 22 de julio de 2017

SCRIP cambia de manos...



 El "confidencial" más reconocido (y fiable) del mundo farma  cambia de manos...


Integrated Medhealth Communication group acquires Script Medical Writing 

The Canadian group brings a wealth of scientific writing expertise to IMC 

IMCIndependent medical communications agency Integrated Medhealth Communication (IMC) has acquired Toronto-based Script Medical Writing as part of the expansion plans for its North American office. 

London-headquartered IMC is looking to the deal to boost its scientific writing expertise and talent as well as bring what it says will be a significant number of new pharmaceutical and biotech clients. 

Shairose Ebrahim, founder and CEO of the IMC group, said: “I am delighted to welcome the Script team to IMC NA. This acquisition is a testament to our unprecedented growth and success in the North American market and will strengthen our position as a leader in scientific communications globally.
 
Alguna vez fuimos noticia en sus páginas...

Script was established in 1998 and has developed medical content including peer-reviewed journals and abstracts, posters and presentations for international congress across multiple therapy areas. 

Increasing our scientific writing expertise through Script, combined with our capabilities in developing innovative medical communications solutions, will provide added value to our clients and enable us to help them achieve greater success with their brands and communication programmes,” said Dr Azhar Rana, vice president and managing director of IMC North America. (Ver)